FORGOTTEN HISTORY: 2 - Caught on Camera

The Real Reason Johnson & Johnson Switched to Corn Starch — Too Late to Save Its Reputation?

Johnson & Johnson's belated shift from talc to corn starch in its baby powders came amid mounting litigation—but can it repair the damage to its reputation?

International Business Times UK · Oct 16, 2025

‘When I was a child, everyone used it’: woman blames Johnson & Johnson talc for her cancer

Sue Rizzello is among thousands in UK suing the firm, which denies selling baby powder containing asbestos

The Guardian - UK · Oct 16, 2025

Johnson & Johnson Reportedly Faces Major UK Lawsuit Over Baby Powder Cancer Risks

A legal claim involving 3,000 people has been reportedly filed against Johnson Johnson (NYSE:JNJ) in the U.K., alleging that the company knowingly sold asbestos-contaminated baby powder.

Benzinga · Oct 16, 2025

Why This Dividend King Still Stands Tall

With a strong product portfolio and growth prospects in innovative medicines, this dividend stock is likely to maintain its 63-year streak of dividend increases.

Barchart · Sep 24, 2025

Tylenol maker Kenvue blasts Trump administration's autism claim

The over-the-counter drug is a critical product for Kenvue.

Axios · Sep 22, 2025

Johnson & Johnson Showcases Positive AFib Data, Treatment Results

Johnson Johnson (NYSE:JNJ) reported new cardiovascular data at the 2025 European Society of Cardiology Congress.

Benzinga · Sep 2, 2025

These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth

As the healthcare sector lags broader markets, AbbVie’s innovation in immunology and Johnson & Johnson’s MedTech expansion make these dividend giants standout bargains at below-market valuations

Barchart · Aug 28, 2025

J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs

Johnson Johnson (NYSE:JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs proposed by the Trump administration.

Benzinga · Aug 22, 2025

“Impressive value for guitarists seeking rich clean/overdrive tones and timeless distortion tones”: PRS Archon Classic Head review

The PRS Archon Classic runs the gamut from crystal cleans to classic crunch and hot-rodded high gain

Guitar World · Jul 27, 2025

2 Recession-Proof Dividend Stocks to Buy for the Second Half of 2025

These blue-chip stocks offer a rare combination of stability, resilience, and moderate growth.

Barchart · Jul 23, 2025